Moreover, our findings highlight that, in the absence of exogenous citrulline (i.e., in commercial media), ASS1-proficient breast cancer cells also produce argininosuccinate mainly via reversed ASL activity. The gene discussed is ASS1; the disease is breast carcinoma.